{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:15:17Z","timestamp":1790716517147,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ajog.2024.05.044","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T15:36:23Z","timestamp":1716824183000},"page":"386-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hormonal contraception and medical readiness for female service members"],"prefix":"10.1016","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7743-7786","authenticated-orcid":false,"given":"Emily A.","family":"Ricker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen J.","family":"Koltun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"de la Motte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2024.05.044_bib1","series-title":"Office of the Under Secretary of Defense for Personnel and Readiness. 2022. Individual Medical Readiness Program (DoD Instruction 6025.19)","year":"2022"},{"key":"10.1016\/j.ajog.2024.05.044_bib3","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s40279-020-01317-5","article-title":"The effects of oral contraceptives on exercise performance in women: a systematic review and meta-analysis","volume":"50","author":"Elliott-Sale","year":"2020","journal-title":"Sports Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40279-023-01911-3","article-title":"The effect of hormonal contraceptive use on skeletal muscle hypertrophy, power and strength adaptations to resistance exercise training: a systematic review and multilevel meta-analysis","volume":"54","author":"Nolan","year":"2024","journal-title":"Sports Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib5","doi-asserted-by":"crossref","first-page":"329.e1-8","DOI":"10.1016\/j.ajog.2008.12.052","article-title":"Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use","volume":"200","author":"Berenson","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.044_bib6","first-page":"1030","article-title":"Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use","volume":"52","author":"Burkman","year":"2007","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.contraception.2005.05.008","article-title":"Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive","volume":"72","author":"O'Connell","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0010-7824(00)00106-2","article-title":"Collagen metabolism markers as a reflection of bone and soft tissue turnover during the menstrual cycle and oral contraceptive use","volume":"61","author":"Wreje","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib9","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1210\/jc.2018-02143","article-title":"Impact of route of estrogen administration on bone turnover markers in oligoamenorrheic athletes and its mediators","volume":"104","author":"Singhal","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.05.044_bib10","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1210\/jc.2003-030033","article-title":"Effects of a triphasic combination oral contraceptive containing norgestimate\/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea","volume":"88","author":"Grinspoon","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.05.044_bib11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fendo.2020.00334","article-title":"Are the effects of oral and vaginal contraceptives on bone formation in young women mediated via the growth hormone-IGF-I axis?","volume":"11","author":"Allaway","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2024.05.044_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.contraception.2005.03.007","article-title":"Effects of an oral contraceptive (norgestimate\/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study","volume":"72","author":"Warren","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib13","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1139\/H08-033","article-title":"Associations of oral contraceptive use and dietary restraint with bone speed of sound and bone turnover in university-aged women","volume":"33","author":"Di Giovanni","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.ajog.2024.05.044_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/8756-3282(95)00075-O","article-title":"Decreased bone turnover in oral contraceptive users","volume":"16","author":"Garnero","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.ajog.2024.05.044_bib15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S8756-3282(00)00403-8","article-title":"Exercise and oral contraceptive use suppress the normal age-related increase in bone mass and strength of the femoral neck in women 18-31 years of age","volume":"27","author":"Burr","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.ajog.2024.05.044_bib16","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.bone.2007.01.008","article-title":"A\u00a0cross-sectional study of bone turnover markers in healthy premenopausal women","volume":"40","author":"de Papp","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.ajog.2024.05.044_bib17","first-page":"576","article-title":"A\u00a0prospective, controlled study of the effects of hormonal contraception on bone mineral density","volume":"98","author":"Berenson","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.044_bib18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0002-9378(97)70396-X","article-title":"Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months","volume":"176","author":"Hergenroeder","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.044_bib19","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1249\/mss.0b013e318074e532","article-title":"The effect of oral contraceptives on bone mass and stress fractures in female runners","volume":"39","author":"Cobb","year":"2007","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.ajog.2024.05.044_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.contraception.2006.06.005","article-title":"Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles","volume":"74","author":"Hartard","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.contraception.2003.10.002","article-title":"A\u00a03-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral density","volume":"69","author":"Endrikat","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0010-7824(03)00025-8","article-title":"Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study","volume":"67","author":"Nappi","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.AOG.0000148344.26475.fc","article-title":"Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density","volume":"105","author":"Nappi","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.044_bib24","article-title":"Steroidal contraceptives: effect on bone fractures in women","volume":"2014","author":"Lopez","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2024.05.044_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/036354658801600302","article-title":"Menstrual irregularity and stress fractures in collegiate female distance runners","volume":"16","author":"Barrow","year":"1988","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/13625187.2016.1217327","article-title":"Combined hormonal contraception and its effects on mood: a critical review","volume":"21","author":"Schaffir","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2024.05.044_bib27","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.fertnstert.2017.02.120","article-title":"A\u00a0first-choice combined oral contraceptive influences general well-being in healthy women: a double-blind, randomized, placebo-controlled trial","volume":"107","author":"Zethraeus","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.05.044_bib28","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1093\/humrep\/der269","article-title":"Hormonal contraception and mental health: results of a population-based study","volume":"26","author":"Toffol","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.05.044_bib29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2012.02.014","article-title":"Further evidence for lack of negative associations between hormonal contraception and mental health","volume":"86","author":"Toffol","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.contraception.2006.08.002","article-title":"Is there an association between the use of oral contraception and depressive symptoms in young Australian women?","volume":"75","author":"Duke","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejogrb.2008.07.018","article-title":"Adverse mood effects of combined oral contraceptives in relation to personality traits","volume":"141","author":"Borgstrom","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2024.05.044_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/13625187.2017.1422239","article-title":"Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use","volume":"23","author":"Bengtsdotter","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2024.05.044_bib33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0010-7824(02)00314-1","article-title":"Attitudes and experiences with levonorgestrel 100 microg\/ethinyl estradiol 20 microg among women during a 3-month trial","volume":"65","author":"Wimberly","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.psyneuen.2017.02.025","article-title":"The levonorgestrel-releasing intrauterine device potentiates stress reactivity","volume":"80","author":"Aleknaviciute","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ajog.2024.05.044_bib35","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1080\/09513590.2017.1306850","article-title":"Weight gain, body image and sexual function in young patients treated with contraceptive vaginal ring. A prospective pilot study","volume":"33","author":"Morotti","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.05.044_bib36","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/aje\/kwt188","article-title":"Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States","volume":"178","author":"Keyes","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2024.05.044_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.contraception.2009.09.011","article-title":"Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study","volume":"81","author":"Massaro","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/S0015-0282(01)02555-9","article-title":"A\u00a0comparative assessment of ORTHO EVRA\u2122\/EVRA\u2122 to placebo patch effects on body weight","volume":"76","author":"Sibai","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.05.044_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1742-4755-11-33","article-title":"Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: a prospective study","volume":"11","author":"Hernandez-Juarez","year":"2014","journal-title":"Reprod Health"},{"key":"10.1016\/j.ajog.2024.05.044_bib40","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.AOG.0000160430.61799.f6","article-title":"Extended use of transdermal norelgestromin\/ethinyl estradiol: a randomized trial","volume":"105","author":"Stewart","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.044_bib41","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00404-015-3784-0","article-title":"Body composition and bone mineral density in users of the etonogestrel-releasing contraceptive implant","volume":"292","author":"Modesto","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2024.05.044_bib42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/humrep\/15.1.118","article-title":"Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception","volume":"15","author":"Beerthuizen","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.05.044_bib43","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.contraception.2013.03.004","article-title":"Weight change at 12 months in users of three progestin-only contraceptive methods","volume":"88","author":"Vickery","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ijgo.12901","article-title":"Comparison of weight gain between levonorgestrel and etonogestrel implants after 12 months of insertion","volume":"147","author":"Okunola","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2024.05.044_bib45","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.contraception.2016.12.006","article-title":"Changes in body composition in women using long-acting reversible contraception","volume":"95","author":"Silva Dos Santos","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib46","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.contraception.2012.01.017","article-title":"Body weight and composition in users of levonorgestrel-releasing intrauterine system","volume":"86","author":"Dal'Ava","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib47","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/humrep\/dei457","article-title":"A\u00a0cross-sectional study of the forearm bone density of long-term users of levonorgestrel-releasing intrauterine system","volume":"21","author":"Bahamondes","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.05.044_bib48","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/humrep\/deq043","article-title":"Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system","volume":"25","author":"Bahamondes","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.05.044_bib49","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40264-018-0683-x","article-title":"Cohort study of psychiatric adverse events following exposure to levonorgestrel-containing intrauterine devices in UK general practice","volume":"41","author":"Slattery","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajog.2024.05.044_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100800","article-title":"Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: findings from a randomised, multicentre, open-label trial","volume":"34","author":"Beksinska","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ajog.2024.05.044_bib51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1590\/2359-3997000000202","article-title":"Body composition, resting energy expenditure and inflammatory markers: impact in users of depot medroxyprogesterone acetate after 12 months follow-up","volume":"61","author":"Batista","year":"2017","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.05.044_bib52","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0010-7824(01)00255-4","article-title":"Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years","volume":"64","author":"Bahamondes","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.contraception.2009.07.007","article-title":"Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception","volume":"81","author":"Beksinska","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib54","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/sj.ijo.0803023","article-title":"Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception","volume":"29","author":"Clark","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.ajog.2024.05.044_bib55","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.contraception.2014.03.011","article-title":"Body weight and body composition of depot medroxyprogesterone acetate users","volume":"90","author":"Dal'Ava","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib56","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3109\/13625187.2014.936934","article-title":"Body composition and weight gain in new users of the three-monthly injectable contraceptive, depot-medroxyprogesterone acetate, after 12 months of follow-up","volume":"19","author":"dos Santos Pde","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2024.05.044_bib57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.contraception.2009.07.008","article-title":"Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive","volume":"81","author":"Pantoja","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/13625187.2014.951433","article-title":"Weight\u00a0variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use","volume":"20","author":"Modesto","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2024.05.044_bib59","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.contraception.2010.07.027","article-title":"The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD)\u00a0and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age","volume":"83","author":"Gai","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/bmjmilitary-2020-001745","article-title":"Hormonal contraceptive use, bone density and biochemical markers of bone metabolism in British Army recruits","volume":"169","author":"Coombs","year":"2023","journal-title":"BMJ Mil Health"},{"key":"10.1016\/j.ajog.2024.05.044_bib61","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00198-016-3714-4","article-title":"The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK","volume":"28","author":"Kyvernitakis","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ajog.2024.05.044_bib62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s001980170155","article-title":"The impact of lifestyle factors on stress fractures in female army recruits","volume":"12","author":"Lappe","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ajog.2024.05.044_bib63","first-page":"47","article-title":"Providing quality planning services: recommendations from CDC and the U.S. Office of Population Affairs","volume":"63","author":"Gavin","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ajog.2024.05.044_bib64","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1093\/milmed\/usad308","article-title":"Selection, initiation, continuation, and efficacy of reversible contraception among enlisted U.S. service women in their first term of service from 2012 to 2020","volume":"189","author":"Roberts","year":"2024","journal-title":"Mil Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib65","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/milmed\/usab194","article-title":"Decide\u00a0+ Be Ready: a contraceptive decision-making mobile application for servicewomen","volume":"186","author":"Witkop","year":"2021","journal-title":"Mil Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib66","article-title":"Influence of \u201cDecide\u00a0+ Be Ready\u201d contraceptive decision aid on pre-deployment health decisions","author":"Wilcox","year":"2022","journal-title":"Mil Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib67","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41073-016-0007-6","article-title":"Sex and gender equity in research: rationale for the SAGER guidelines and recommended use","volume":"1","author":"Heidari","year":"2016","journal-title":"Res Integr Peer Rev"},{"key":"10.1016\/j.ajog.2024.05.044_bib69","series-title":"Defense Health Agency. 2019. Comprehensive Contraceptive Counseling and Access to the Full Range of Methods of Contraception (DHA-Procedural Instruction 6200.02)","year":"2019"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2024.05.044_bib70","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/milmed\/usac354","article-title":"Improving the health and readiness of military\u00a0women","volume":"188","author":"Witkop","year":"2023","journal-title":"Mil Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib72","first-page":"8","article-title":"Update: contraception among active component service women, U.S. Armed Forces, 2017-2021","volume":"29","year":"2022","journal-title":"MSMR"},{"key":"10.1016\/j.ajog.2024.05.044_bib73","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.contraception.2019.04.002","article-title":"Contraceptive use and childbirth rates by service branch during the first 24 months on active duty in the United States military from 2013 to 2018: a retrospective cohort analysis","volume":"100","author":"Roberts","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib74","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.contraception.2011.01.017","article-title":"Unintended pregnancy among women in the US military","volume":"84","author":"Lindberg","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2022.09.132","article-title":"Unintended pregnancy among U.S. military active duty servicemembers: estimates for 2018 and trends since 2005","volume":"119","author":"Hamrick","year":"2023","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib76","first-page":"2","article-title":"Medical evacuations from Afghanistan during operation enduring freedom, active and reserve components, U.S. Armed Forces, 7 October 2001-31 December 2012","volume":"20","year":"2013","journal-title":"MSMR"},{"key":"10.1016\/j.ajog.2024.05.044_bib77","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/GCO.0000000000000414","article-title":"Contraception in US servicewomen: emerging knowledge, considerations, and needs","volume":"29","author":"Harrington","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1016\/j.ajog.2024.05.044_bib78","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/AOG.0b013e31827c616e","article-title":"Unintended pregnancy among active-duty women in the United States military, 2008","volume":"121","author":"Grindlay","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.044_bib79","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/milmed\/166.12.1033","article-title":"Issues for military women in deployment: an overview","volume":"166","author":"Ritchie","year":"2001","journal-title":"Mil Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib80","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3357\/ASEM.2566.2009","article-title":"Menstrual suppression using oral contraceptives: survey of deployed female aviation personnel","volume":"80","author":"Powell-Dunford","year":"2009","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib81","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.whi.2010.08.006","article-title":"Menstrual suppression for combat operations: advantages of oral contraceptive pills","volume":"21","author":"Powell-Dunford","year":"2011","journal-title":"Women Health Issues"},{"key":"10.1016\/j.ajog.2024.05.044_bib82","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/milmed\/168.11.922","article-title":"Attitudes and knowledge about continuous oral contraceptive pill use in military women","volume":"168","author":"Powell-Dunford","year":"2003","journal-title":"Mil Med"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2024.05.044_bib83","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/milmed\/usaa339","article-title":"Female military officers report a desire for menstrual suppression during military training","volume":"186","author":"Ricker","year":"2021","journal-title":"Mil Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib84","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/AOG.0000000000004899","article-title":"General approaches to medical management of menstrual suppression: ACOG Clinical Consensus No. 3","volume":"140","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.044_bib85","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-7824(95)00074-K","article-title":"Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation","volume":"51","author":"Rosenberg","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib86","first-page":"355","article-title":"Unintended pregnancies and use, misuse and discontinuation of oral contraceptives","volume":"40","author":"Rosenberg","year":"1995","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib87","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpag.2019.03.008","article-title":"Assessing weight status in adolescent and young adult users of the etonogestrel contraceptive implant","volume":"32","author":"Romano","year":"2019","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.ajog.2024.05.044_bib88","series-title":"Office of the Under Secretary of Defense for Personnel and Readiness. 2022. DoD Physical Fitness\/Body Composition Program (DoD Instruction 1308.03)","year":"2022"},{"key":"10.1016\/j.ajog.2024.05.044_bib89","series-title":"American Security Project. 2023. Combating Military Obesity: Stigma\u2019s Persistent Impact on Operational Readiness. American Security Project","year":"2023"},{"key":"10.1016\/j.ajog.2024.05.044_bib90","first-page":"11","article-title":"Increased prevalence of overweight and obesity and incidence of prediabetes and type 2 diabetes during the COVID-19 pandemic, active component service members, U.S. Armed Forces, 2018 to 2021","volume":"30","author":"Stiegmann","year":"2023","journal-title":"MSMR"},{"key":"10.1016\/j.ajog.2024.05.044_bib91","series-title":"Army Public Health Center (Provisional) Aberdeen Proving Ground United States. 2015. Health of the Force.","year":"2015"},{"key":"10.1016\/j.ajog.2024.05.044_bib92","article-title":"Combination contraceptives: effects on weight","volume":"2014","author":"Gallo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2024.05.044_bib93","article-title":"Progestin-only contraceptives: effects on weight","volume":"2016","author":"Lopez","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2024.05.044_bib94","series-title":"AHRQ comparative effectiveness reviews. Strategies to prevent weight gain among adults","author":"Hutfless","year":"2013"},{"key":"10.1016\/j.ajog.2024.05.044_bib95","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1089\/jwh.2021.0292","article-title":"Sex differences in the incidence and risk of ankle-foot complex stress fractures among U.S. Military Personnel","volume":"31","author":"MacGregor","year":"2022","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2024.05.044_bib96","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/milmed\/165.7.515","article-title":"Injuries during Marine Corps officer basic training","volume":"165","author":"Piantanida","year":"2000","journal-title":"Mil Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib97","article-title":"Incidence and time to return to training for stress fractures during military basic training","volume":"2014","author":"Wood","year":"2014","journal-title":"J\u00a0Sports Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib98","doi-asserted-by":"crossref","first-page":"936","DOI":"10.7205\/MILMED.172.9.936","article-title":"Factors associated with discharge during marine corps basic training","volume":"172","author":"Reis","year":"2007","journal-title":"Mil Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib99","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.mjafi.2018.09.006","article-title":"Stress fractures in military recruits: a prospective study for evaluation of incidence, patterns of injury and invalidments out of service","volume":"75","author":"Takkar","year":"2019","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.ajog.2024.05.044_bib100","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.tem.2012.03.008","article-title":"Estrogen and the skeleton","volume":"23","author":"Khosla","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.05.044_bib101","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.7205\/MILMED-D-15-00571","article-title":"Epidemiology of lower extremity stress fractures in the United States military","volume":"181","author":"Waterman","year":"2016","journal-title":"Mil Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib102","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7205\/MILMED-D-10-00322","article-title":"Females have a greater incidence of stress fractures than males in both military and athletic populations: a systemic review","volume":"176","author":"Wentz","year":"2011","journal-title":"Mil Med"},{"key":"10.1016\/j.ajog.2024.05.044_bib103","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12891-019-2634-9","article-title":"A\u00a0prospective field study of U.S. Army trainees to identify the physiological bases and key factors influencing musculoskeletal injuries: a study protocol","volume":"20","author":"Hughes","year":"2019","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.ajog.2024.05.044_bib104","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.contraception.2006.03.022","article-title":"Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives","volume":"74","author":"Sabatini","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.05.044_bib105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijgo.2011.03.008","article-title":"Combined contraceptive ring versus combined oral contraceptive (30-\u03bcg ethinylestradiol and 3-mg drospirenone)","volume":"114","author":"Mohamed","year":"2011","journal-title":"Int\u00a0J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2024.05.044_bib106","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/15622975.2022.2145354","article-title":"The potential association between psychiatric symptoms and the use of levonorgestrel intrauterine devices (LNG-IUDs): a systematic review","volume":"24","author":"Elsayed","year":"2023","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.ajog.2024.05.044_bib107","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.psyneuen.2016.11.036","article-title":"Cortisol stress reactivity across psychiatric disorders: a systematic review and meta-analysis","volume":"77","author":"Zorn","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ajog.2024.05.044_bib108","series-title":"Defense Health Agency. 2023. Walk-in Contraception Services at Military Medical Treatment Facilities (DHA Administrative Instruction 6025.09)","year":"2023"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824006306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824006306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T17:45:47Z","timestamp":1726595147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824006306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0002937824006306"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.05.044","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormonal contraception and medical readiness for female service members","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.05.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}